{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:24:53Z","timestamp":1794007493265,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.seminhematol.2023.08.004","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T18:31:28Z","timestamp":1693852288000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["How to set up a clinical research center in Brazil, as an example of a middle-income country"],"prefix":"10.1053","volume":"60","author":[{"given":"Eduardo Fl\u00e1vio Oliveira","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Am\u00e9lia Morais de Lacerda Mangueira","family":"Belmiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenisa Cezar Vilas","family":"Boas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-5242","authenticated-orcid":false,"given":"Carsten Utoft","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.seminhematol.2023.08.004_bib0001","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharmaceut Sin B"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0002","unstructured":"IQVIA The changing landscape of research and development. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports\/the-changing-landscape-of-research-and-development."},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0003","unstructured":"International Monetary Fund. World economic outlook [Internet], 2022. https:\/\/www.imf.org\/pt\/Publications\/WEO\/Issues\/2022\/10\/11\/world-economic-outlook-october-2022 accessed 11.03.2023."},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0004","unstructured":"INTERFARMA. Research Pharmaceutical Industry Association. Interfarma guide 2022 [Internet]. https:\/\/www.interfarma.org.br\/guia-interfarma-2022-ja-esta-disponivel\/ accessed 11.03.2023."},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0005","unstructured":"Gomes R, Pimentel VP, Landim AB, Pieroni JP. Clinical trials in Brazil: international competitiveness and challenges. 2012. https:\/\/www.scielo.br\/j\/bioet\/a\/Bhk4bDL8wYTZtPc6PrpWycQ\/?lang=pt accessed 11.03.2023."},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0006","unstructured":"Ministry of Health. Secretariat of Science, Technology, Innovation and Strategic Inputs in Health. Department of Science and Technology. Clinical research action plan in Brazil, 2020. https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/action_plan_clinical_research_brazil.pdf accessed 11.03.2023."},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0007","volume":"33","author":"Vieira","year":"2017"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0008","series-title":"COPEC Activities Report","year":"2018"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0009","unstructured":"INTERFARMA The importance of clinical research for Brazil [Internet]; 2021 https:\/\/www.interfarma.org.br\/wp-content\/uploads\/2021\/12\/Interfarma_Estudo-Pesquisa-clinica-2021-1.pdf accessed 11.03.2023."},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0010","series-title":"Integrated Addendum to ICH E6 (R1)","year":"2016"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.08.004_bib0011","first-page":"363","article-title":"Clinical research in Brazil","volume":"9","author":"Zago","year":"2004","journal-title":"Public Science & Health, Rio de Janeiro"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.08.004_sbref0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/10601333.2010.480974","article-title":"Addressing issues affecting clinical trials in Brazil","volume":"27","author":"Virk","year":"2010","journal-title":"Clin Res Regulatory Affairs"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.08.004_bib0013","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1590\/S1415-790X2006000400002","article-title":"Clinical trials: national training for drug and vaccine evaluation","volume":"9","author":"Quental","year":"2006","journal-title":"Rev Bras Epidemiol"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0014","series-title":"Clinical research","year":"2022"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.08.004_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12910-020-0460-0","article-title":"Partnering with patients in healthcare research: a scoping review of ethical issues, challenges, and recommendations for practice","volume":"21","author":"Martineau","year":"2020","journal-title":"BMC Med Ethics"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.08.004_bib0016","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mayocpiqo.2020.09.014","article-title":"Empowering the Clinical Research Coordinator in Academic Medical Centers","volume":"5","author":"Buchanan","year":"2021","journal-title":"Mayo Clinic Proc Innov Qual Outcomes"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.08.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2020.150999","article-title":"Good financial practice and clinical research coordinator responsibilities","volume":"36","author":"Jackson","year":"2020","journal-title":"Semin Oncol Nurs"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.08.004_bib0018","doi-asserted-by":"crossref","first-page":"e1204","DOI":"10.1016\/S2214-109X(22)00128-0","article-title":"Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators","volume":"10","author":"Aguilera","year":"2022","journal-title":"Lancet Global Health"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.08.004_bib0019","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/NNA.0000000000000744","article-title":"Fostering academic-clinical research partnerships","volume":"49","author":"Albert","year":"2019","journal-title":"J Nurs Adm"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106843","article-title":"Clinical registries data quality attributes to support registry-based randomised controlled trials: a scoping review","volume":"119","author":"Prang","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.08.004_bib0021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.11613\/BM.2014.022","article-title":"Observational and interventional study design types: an overview","volume":"24","author":"Thiese","year":"2014","journal-title":"Biochemia Medica"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jclinepi.2015.09.009","article-title":"Registration practices for observational studies on ClinicalTrials.gov indicated low adherence","volume":"70","author":"Boccia","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.08.004_bib0023","doi-asserted-by":"crossref","first-page":"733","DOI":"10.20344\/amp.14554","article-title":"Portuguese authorship in published clinical trials: differences in industry and investigator initiated trials","volume":"34","author":"Andrade","year":"2021","journal-title":"Acta M\u00e9d Port"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.08.004_bib0024","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/annonc\/mdq018","article-title":"Investigator-initiated trials of targeted oncology agents: why independent research is at risk?","volume":"21","author":"Bergmann","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.08.004_bib0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12874-020-01125-5","article-title":"Impact of investigator-initiated trials and industry-sponsored trials on medical practice (IMPACT): rationale and study design","volume":"20","author":"Nury","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.08.004_bib0026","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1200\/OP.20.00970","article-title":"Perceived Institutional Barriers Among Clinical and Research Professionals: minority participation in Oncology Clinical Trials","volume":"17","author":"Niranjan","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1053\/j.seminhematol.2023.08.004_bib0027","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/17407745211001522","article-title":"The triple aim of clinical research","volume":"18","author":"Dorsey","year":"2021","journal-title":"Clin Trials"},{"issue":"27_suppl","key":"10.1053\/j.seminhematol.2023.08.004_bib0028","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.2019.37.27_suppl.152","article-title":"Bias and stereotyping among research and clinical professionals: perspectives on minority recruitment for oncology clinical trials","volume":"37","author":"Niranjan","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:29:04Z","timestamp":1758522544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0037196323000690"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.08.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to set up a clinical research center in Brazil, as an example of a middle-income country","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}